Abstract
Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is a technique of external beam radiation that delivers precisely targeted, ablative doses to extracranial sites. It has become an integral component of the management of early-stage non-small cell lung cancer (NSCLC). In this review, we discuss the technology and techniques used in treatment planning and delivery, the efficacy and toxicity of SBRT for medically inoperable early-stage NSCLC, and the preliminary investigations into the role of SBRT for operable early-stage NSCLC.
Original language | English (US) |
---|---|
Pages (from-to) | 274-279 |
Number of pages | 6 |
Journal | Cancer Journal (United States) |
Volume | 22 |
Issue number | 4 |
DOIs | |
State | Published - Jul 26 2016 |
Keywords
- Non-small cell lung cancer
- Stereotactic ablative radiotherapy
- Stereotactic body radiation therapy
ASJC Scopus subject areas
- Cancer Research
- Oncology